Literature DB >> 29023237

Corneal Tissue From Dry Eye Donors Leads to Enhanced Graft Rejection.

Takenori Inomata1, Jing Hua, Takeshi Nakao, Tina Shiang, Homer Chiang, Afsaneh Amouzegar, Reza Dana.   

Abstract

PURPOSE: To assess the effect of dry eye disease (DED) in graft donors on dendritic cell (DC) maturation, host T-cell sensitization, and corneal allograft rejection.
METHODS: Corneas of control (healthy donor) and DED mice (C57BL/6) were transplanted onto fully allogeneic naive BALB/c recipients (n = 10 mice/group). Long-term allograft survival was evaluated for 8 weeks. Corneas and draining lymph nodes (dLNs) were harvested at posttransplantation day 14 (n = 5 mice/group). The frequencies of MHCII CD11c DCs in the donor corneas and host dLNs and the frequencies of interferon (IFN)-γ and IL-17 CD4 T cells and Foxp3 expression by Tregs in host dLNs were investigated using flow cytometry. The enzyme-linked immunospot assay was used to assess host T-cell allosensitization through direct and indirect pathways (n = 3/group).
RESULTS: Recipients of DED donor corneas showed significantly reduced graft survival (10%) compared with control mice (50% survival, P = 0.022), and had significantly increased frequencies of mature DCs in the grafted cornea (DED donor 44.0% ± 0.36% vs. healthy donor 35.4 ± 0.5%; P < 0.0001) and host dLNs (DED donor 25.1% ± 0.66% vs. healthy donor 13.7% ± 1.6%; P = 0.005). Frequencies of IFN-γ and IL-17 T cells were increased in the dLNs of recipients of DED corneas, whereas the expression (mean fluorescence intensity) of Foxp3 in Tregs was decreased significantly in these mice (DED donor 6004 ± 193 vs. healthy donor 6806 ± 81; P = 0.0002). Enzyme-linked immunospot analysis showed that the direct pathway of allosensitization was significantly amplified in recipients of grafts with DED (P = 0.0146).
CONCLUSIONS: Our results indicate that DED in the donor is a significant risk factor for subsequent corneal allograft rejection.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29023237      PMCID: PMC5716893          DOI: 10.1097/ICO.0000000000001400

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  30 in total

1.  Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?

Authors:  Manfred B Lutz; Gerold Schuler
Journal:  Trends Immunol       Date:  2002-09       Impact factor: 16.687

Review 2.  Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease.

Authors:  Stefano Barabino; Yihe Chen; Sunil Chauhan; Reza Dana
Journal:  Prog Retin Eye Res       Date:  2012-03-08       Impact factor: 21.198

3.  Donor-derived, tolerogenic dendritic cells suppress immune rejection in the indirect allosensitization-dominant setting of corneal transplantation.

Authors:  Takaaki Hattori; Daniel R Saban; Parisa Emami-Naeini; Sunil K Chauhan; Toshinari Funaki; Hiroki Ueno; Reza Dana
Journal:  J Leukoc Biol       Date:  2012-01-30       Impact factor: 4.962

4.  Two different regulatory T cell populations that promote corneal allograft survival.

Authors:  Khrishen Cunnusamy; Kathryn Paunicka; Nancy Reyes; Wanhua Yang; Peter W Chen; Jerry Y Niederkorn
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-08-11       Impact factor: 4.799

5.  A novel pro-lymphangiogenic function for Th17/IL-17.

Authors:  Sunil K Chauhan; Yiping Jin; Sunali Goyal; Hyun Soo Lee; Thomas A Fuchsluger; Hyung Keun Lee; Reza Dana
Journal:  Blood       Date:  2011-09-08       Impact factor: 22.113

6.  Draining lymph nodes play an essential role in alloimmunity generated in response to high-risk corneal transplantation.

Authors:  Satoru Yamagami; M Reza Dana; Tadahiko Tsuru
Journal:  Cornea       Date:  2002-05       Impact factor: 2.651

7.  Desiccating stress induces T cell-mediated Sjögren's Syndrome-like lacrimal keratoconjunctivitis.

Authors:  Jerry Y Niederkorn; Michael E Stern; Stephen C Pflugfelder; Cintia S De Paiva; Rosa M Corrales; Jianping Gao; Karyn Siemasko
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

8.  PDE4 inhibition suppresses IL-17-associated immunity in dry eye disease.

Authors:  Zahra Sadrai; William Stevenson; Andre Okanobo; Yihe Chen; Thomas H Dohlman; Jing Hua; Francisco Amparo; Sunil K Chauhan; Reza Dana
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-14       Impact factor: 4.799

9.  Ocular surgical models for immune and angiogenic responses.

Authors:  Takenori Inomata; Alireza Mashaghi; Antonio Di Zazzo; Reza Dana
Journal:  J Biol Methods       Date:  2015-09-21

10.  CD154 blockade modulates the ratio of Treg to Th1 cells and prolongs the survival of allogeneic corneal grafts in mice.

Authors:  Xiaobo Tan; Hui Zeng; Ying Jie; Yingnan Zhang; Qing Xu; Zhiqiang Pan
Journal:  Exp Ther Med       Date:  2014-02-07       Impact factor: 2.447

View more
  12 in total

1.  Different Innate Immune Responses in BALB/c and C57BL/6 Strains following Corneal Transplantation.

Authors:  Tim Bleul; Xinyu Zhuang; Antonia Hildebrand; Clemens Lange; Daniel Böhringer; Günther Schlunck; Thomas Reinhard; Thabo Lapp
Journal:  J Innate Immun       Date:  2020-09-09       Impact factor: 7.349

Review 2.  Prevalence and Characteristics of Dry Eye Disease After Cataract Surgery: A Systematic Review and Meta-Analysis.

Authors:  Maria Miura; Takenori Inomata; Masahiro Nakamura; Jaemyoung Sung; Ken Nagino; Akie Midorikawa-Inomata; Jun Zhu; Keiichi Fujimoto; Yuichi Okumura; Kenta Fujio; Kunihiko Hirosawa; Yasutsugu Akasaki; Mizu Kuwahara; Atsuko Eguchi; Hurramhon Shokirova; Akira Murakami
Journal:  Ophthalmol Ther       Date:  2022-05-09

3.  Regulatory T cell modulation of cytokine and cellular networks in corneal graft rejection.

Authors:  Maryam Tahvildari; Takenori Inomata; Afsaneh Amouzegar; Reza Dana
Journal:  Curr Ophthalmol Rep       Date:  2018-10-06

4.  The purinergic receptor antagonist oxidized adenosine triphosphate suppresses immune-mediated corneal allograft rejection.

Authors:  William Foulsham; Sharad K Mittal; Takeshi Nakao; Giulia Coco; Yukako Taketani; Sunil K Chauhan; Reza Dana
Journal:  Sci Rep       Date:  2019-06-13       Impact factor: 4.379

Review 5.  Dry Eye Disease: Emerging Approaches to Disease Analysis and Therapy.

Authors:  Mostafa Heidari; Farsad Noorizadeh; Kevin Wu; Takenori Inomata; Alireza Mashaghi
Journal:  J Clin Med       Date:  2019-09-11       Impact factor: 4.241

6.  Novel immunotherapeutic effects of topically administered ripasudil (K-115) on corneal allograft survival.

Authors:  Takenori Inomata; Keiichi Fujimoto; Yuichi Okumura; Jun Zhu; Kenta Fujio; Hurramhon Shokirova; Maria Miura; Mikiko Okano; Toshinari Funaki; Jaemyoung Sung; Naoko Negishi; Akira Murakami
Journal:  Sci Rep       Date:  2020-11-13       Impact factor: 4.379

7.  Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation.

Authors:  Hurramhon Shokirova; Takenori Inomata; Tsuyoshi Saitoh; Jun Zhu; Kenta Fujio; Yuichi Okumura; Ai Yanagawa; Keiichi Fujimoto; Jaemyoung Sung; Atsuko Eguchi; Maria Miura; Ken Nagino; Kunihiko Hirosawa; Mizu Kuwahara; Yasutsugu Akasaki; Hiroshi Nagase; Akira Murakami
Journal:  Sci Rep       Date:  2021-04-21       Impact factor: 4.379

8.  Ex Vivo-Induced Bone Marrow-Derived Myeloid Suppressor Cells Prevent Corneal Allograft Rejection in Mice.

Authors:  Jun Zhu; Takenori Inomata; Keiichi Fujimoto; Koichiro Uchida; Kenta Fujio; Ken Nagino; Maria Miura; Naoko Negishi; Yuichi Okumura; Yasutsugu Akasaki; Kunihiko Hirosawa; Mizu Kuwahara; Atsuko Eguchi; Hurramhon Shokirova; Ai Yanagawa; Akie Midorikawa-Inomata; Akira Murakami
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-06-01       Impact factor: 4.799

9.  Pathological conversion of regulatory T cells is associated with loss of allotolerance.

Authors:  Jing Hua; Takenori Inomata; Yihe Chen; William Foulsham; William Stevenson; Tina Shiang; Jeffrey A Bluestone; Reza Dana
Journal:  Sci Rep       Date:  2018-05-04       Impact factor: 4.379

Review 10.  Variable Responses to Corneal Grafts: Insights from Immunology and Systems Biology.

Authors:  Antonio Di Zazzo; Sang-Mok Lee; Jaemyoung Sung; Matteo Niutta; Marco Coassin; Alireza Mashaghi; Takenori Inomata
Journal:  J Clin Med       Date:  2020-02-21       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.